On this page...
Contact Us
Dana Wolff-Hughes, Ph.D.
Program Director, Risk Factor Assessment Branch
dana.wolff@nih.gov
Overview
Digital health is a multidisciplinary area that encompasses many domains including health IT, mobile health, wearable devices, telehealth, and personalized medicine, as well as the data infrastructure and ecosystem to enable integration and analysis of data from these technologies. Digital health approaches can significantly advance the assessment, monitoring, and understanding of cancer risk factors and determinants and increase participant reach and engagement in cancer research.
Related Funding Opportunities
NCI is currently participating in the following funding opportunities:
- Notice of NIH Participation in the National Science Foundation Solicitation NSF 23-614: Smart Health and Biomedical Research in the Era of Artificial Intelligence and Advanced Data Science
- Notice of Special Interest: Technology Development for Cancer Control and Population Science Research – expires December 31, 2024
- Notice of Special Interest (NOSI): Validation of Digital Health and Artificial Intelligence/Machine Learning Tools for Improved Assessment in Biomedical and Behavioral Research - expires July 6, 2025
- Digital Health Technology Derived Biomarkers and Outcome Assessments for Remote Monitoring and Endpoint Development - expires June 23, 2026
- PAR-25-170, UG3/UH3 - Clinical Trial Optional
Research Resources
- Informed Consent for Research Using Digital Health Technologies: Points to Consider and Sample Language
This NIH resource presents general points to consider, instructions for use, and optional sample language for the research community. This resource will best be used to inform research teams and Institutional Review Board (IRB) members who are planning, reviewing, or conducting research that studies or uses digital health technologies.
Related Webinars
- Smart Health Frontiers: Combating Cancer with Advanced Technologies (October 29, 2024)